# Iambic Therapeutics IPO (IAM): price, date and first-day trading

> Iambic Therapeutics (IAM) priced its IPO at $16.00 a share and has traded on Nasdaq since Oct 15, 2026.

Canonical: https://massive.com/quote/iam/ipo
Data as of: 2026-11-19T10:16:06.242Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## IAM price

| Figure | Value |
| --- | --- |
| Price | $14.60 |
| Change from the IPO price | -8.75% |
| Change today | +2.67% |

## The IPO scoreboard

IAM against other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

| IPO | Raised | First trade | Day 1 close | Day 5 | Day 30 |
| --- | --- | --- | --- | --- | --- |
| Iambic Therapeutics | $150M | +0.94% | +18.19% | -1.38% | Not yet |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |

## The offering

| Term | Value |
| --- | --- |
| Expected price range | $15 to $17 |
| IPO price | $16.00 |
| Shares offered | 9.38M |
| Money raised | $150M |
| Listing date | Oct 15, 2026 |
| Exchange | Nasdaq |
| Security | Ordinary Shares |

## Where IAM ranks

The company's market cap against the largest US-listed companies.

| Company | Market cap |
| --- | --- |
| AAPL | $5.12T |
| MSFT | $3.77T |
| NVDA | $3.65T |
| GOOGL | $3.47T |
| AMZN | $2.9T |
| TSM | $1.88T |
| AVGO | $1.69T |
| META | $1.58T |
| TSLA | $1.52T |
| BRK.B | $1.22T |
| IAM | $699.64M |

## What comes after the IPO

Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.

- Oct 15, 2026: First trade. Prices, bars, and snapshots
- Oct 20, 2026 · est.: Options list. Option chain and open interest
- Nov 4, 2026 · est.: First short interest. Short interest and daily short volume
- Nov 9, 2026 · est.: Quiet period ends. Analyst ratings and price targets
- Feb 14, 2027: First 13F deadline. Which funds hold the stock
- Date not set: First earnings. Income statement and ratios
- Apr 12, 2027 · est.: Lock-up expires. Insider sales on Form 4

## Filings and the company

Material events that Iambic Therapeutics has disclosed to the SEC on Form 8-K.

- Oct 16, 2026 · Charter amendment ([filing](https://www.sec.gov/Archives/edgar/data/1997038/0001193125-26-424242.txt))

## FAQ

### What was the Iambic Therapeutics IPO price?

$16.00 a share.

### When did Iambic Therapeutics go public?

Iambic Therapeutics listed on Nasdaq on Oct 15, 2026 under the ticker IAM.

### How much did the Iambic Therapeutics IPO raise?

$150M, before any underwriters' option.

### How did Iambic Therapeutics open on its first day?

IAM first traded at $16.15, +0.94% from the IPO price of $16.00.

### How did IAM close on its first day?

Its last regular-session trade was $18.91, +18.19% from the IPO price of $16.00.

### What was the IAM first-day trading range?

$16.15 to $19.70 in the regular session.

### How many IAM shares traded on the first day?

1.93M shares in the regular session.

### How many shares did Iambic Therapeutics sell in its IPO?

9.38M shares.

### What exchange is IAM listed on?

Iambic Therapeutics lists on Nasdaq under the ticker IAM.

### Are the prices on this page real time?

No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.

## Live data

The IPO record and the price come from the Massive API.

- `GET https://api.massive.com/vX/reference/ipos?ticker=IAM`
- `GET https://api.massive.com/v3/snapshot?ticker.any_of=IAM`
- `GET https://api.massive.com/v2/aggs/ticker/IAM/range/5/minute/{date}/{date}`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Markets overview](https://massive.com/quote/index.md)
- [Insider trading](https://massive.com/quote/insider-trading.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
